NCT04764526 is a NA clinical trial of Protein-enriched ice cream in Protein Intake, sponsored by Inge Tetens.

Who is sponsoring NCT04764526?

NCT04764526 is sponsored by Inge Tetens.

What drugs are being tested in NCT04764526?

Interventions in NCT04764526: Protein-enriched ice cream.

What condition does NCT04764526 study?

NCT04764526 studies Protein Intake.

Is NCT04764526 still recruiting?

NCT04764526 is currently completed. Last updated 17 August 2021.

Last reviewed 2021-08-17 · How we verify

NCT04764526

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ice Cream Enriched With Protein and Positive Emotions

Completed NA Last updated 17 August 2021

What this trial tests

NA trial testing Protein-enriched ice cream in Protein Intake in 8 participants. Completed in 30 July 2021.

Timeline

14 April 2021

Primary endpoint
30 July 2021

30 July 2021

Quick facts

Lead sponsor	Inge Tetens
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	prevention
Enrollment	8
Start date	14 April 2021
Primary completion	30 July 2021
Estimated completion	30 July 2021
Sites	1 location across Denmark

Drugs / interventions tested

Protein-enriched ice cream

Conditions studied

Protein Intake — all drugs for Protein Intake →

Sponsor

Inge Tetens

Who can join

65 and older, any sex, with Protein Intake. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary aim is to investigate if protein-enriched ice cream has the feasibility to increase intake of protein without substituting other foods in hospitalized older patients and secondary, if the protein-enriched ice cream has the feasibility to increases the energy intake and evokes positive emotions in older hospitalized patients

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Protein Intake

Currently open trials in the same condition.

NCT05355090 — Daily Protein Pacing Effects on HbA1c in Type 2 Diabetics · NA · active not recruiting

Other Inge Tetens trials

Trials by the same sponsor.

NCT05600530 — Validity and Reproducibility of Dietary Assessment Against Objective Measures · completed
NCT04550078 — The Postprandial Calcium Absorption of a Milk Derived Calcium Permeate - RENEW Acute Study · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04764526 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Inge Tetens
Last refreshed: 17 August 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04764526.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing